Keywords
References
- The natural history of schizophrenia in the long term.Br J Psychiatry. 1980; 136: 413-420
- Emerging adulthood: a theory of development from the late teens through the twenties.Am Psychol. 2000; 55: 469-480
- Epidemiology of schizophrenia: review of findings and myths.Psychiatr Clin North Am. 2007; 30: 323-338
- Age-at-first-registration for affective psychosis and schizophrenia.Schizophr Bull. 2004; 30: 849-853
- A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?.Arch Gen Psychiatry. 2007; 64: 1123-1131
- Sporadic cases are the norm for complex disease.Eur J Hum Genet. 2010; 18: 1039-1043
- Strong association of de novo copy number mutations with sporadic schizophrenia.Nat Genet. 2008; 40: 880-885
Available at: http://www.nimh.nih.gov/health/statistics/prevalence/schizophrenia.shtml. Accessed August 18, 2016.
- Schizophrenia, “Just the Facts” what we know in 2008. 2. Epidemiology and etiology.Schizophr Res. 2008; 102: 1-18
- Practice guideline for treatment of patients with schizophrenia, second edition.Am J Psychiatry. 2004; 161: 1-56
- The nature of relapse in schizophrenia.BMC Psychiatry. 2013; 13: 50
Available at: http://www.tapartnership.org/SOC/SOCvalues.php. Accessed September 1, 2016.
- Psychotic disorders in youth.Child Adolesc Psychiatr Clin N Am. 2013; 22
- Diagnostic and statistical manual of mental disorders.5th edition. American Psychiatric Association, Arlington (VA)2013
Phillips J. Diagnosing schizophrenia from DSM II to DSM-5: A Quiz. Psychiatric Times. July 2011. Available at: http://www.psychiatrictimes.com/schizophrenia/diagnosing-schizophrenia-dsm-ii-dsm-5-quiz. Accessed August 28, 2016.
- Childhood onset schizophrenia and early onset schizophrenia spectrum disorders.Child Adolesc Psychiatr Clin N Am. 2013; 22: 539-555
- Community rehabilitation and psychosocial interventions for psychotic disorders in youth.Child Adolesc Psychiatr Clin N Am. 2013; 22: 745-758
Cavanaugh D, Goldman S, Friesen B, et al. Designing a recovery-oriented care model for adolescents and transition age youth with substance use or co-occurring mental health disorders: Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment and Center for Mental Health Services; 2009. Report from CSAT/CMHS/SAMHSA Consultative Session. November 13–14, 2008. Available at: https://gucchdtacenter.georgetown.edu/resources/Recovery_Report_Adolescents%20-%20FINAL.pdf. Accessed January 18, 2017.
- Special needs: scholastic disability accommodations from K-12 and transitions to higher education.Curr Psychiatry Rep. 2016; 18: 21
American Psychiatric Association. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th text revision edition. Washington, DC: American Psychaitric Association; 2000.
- DSM-5 and the assessment of functioning: The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0).J Am Acad Psychiatry Law. 2014; 42: 173-181
- Clinical characteristics and predictors of outcome of schizophrenia-spectrum psychosis in children and adolescents: a systematic review.J Child Adolesc Psychopharmacol. 2016; 26: 410-427
- Schizophrenia on YouTube.Psychiatr Serv. 2016; https://doi.org/10.1176/appo.ps.201500541
- Autism-spectrum disorders and childhood onset schizophrenia: clinical and biological contributions to a relationship revisited.J Am Acad Child Adolesc Psychiatry. 2009; 48: 10-18
- “Autism-plus” spectrum disorders: intersection with psychosis and the schizophrenia spectrum.Child Adolesc Psychiatr Clin N Am. 2013; 22: 609-627
- The McLean-Harvard first-episode project: early course in 114 cases of first-episode nonaffective psychoses.J Clin Psychiatry. 2016; 77: 781-788
- Boundaries of schizoaffective disorder revisiting Kraepelin.JAMA Psychiatry. 2013; 70: 1276-1286
- What we know and what we don't know about the treatment of schizoaffective disorder.J Euroneuro. 2011; 21: 680-690
- Characteristics and heterogeneity of schizoaffective disorder compared with unipolar depression and schizophrenia - a systematic literature review and meta-analysis.J Affect Disord. 2016; 191: 8-14
- Childhood traumas and hallucinations: an analysis of the National Comorbidity Study.J Psychiatr Res. 2007; 41: 222-228
- Childhood trauma and auditory verbal hallucinations.Psychol Med. 2012; 42: 2475-2484
- The relation of childhood maltreatment to psychotic symptoms in adolescents and young adults with depression.J Clin Child Adolesc Psychol. 2016; 45: 241-247
- Childhood trauma and psychosis.Child Adolesc Psychiatr Clin N Am. 2013; 22: 629-643
- Substance abuse and psychosis.Child Adolesc Psychiatr Clin N Am. 2013; 22: 643-654
- Substance use, abuse and dependence in adolescence: prevalence, symptom profiles and correlates.Drug Alcohol Depend. 2002; 68: 309-322
- An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions.J Addict Med. 2011; 5: 1-8
- Differences in clinical features of methamphetamines users with persistent psychosis and patients with schizophrenia.Psychopathology. 2016; 49: 108-115
- Methamphetamine-associated psychosis.J Neuroimmune Pharmacol. 2012; 7: 113-139
- DSM-V research agenda: substance abuse/psychosis comorbidity.Schizophr Bull. 2007; 33: 947-952
- Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement.Addict Behav. 2013; 38: 1764-1775
- Cannabis, psychosis, and mortality: a cohort study of 50,373 Swedish men.Am J Psychiatry. 2016; 173: 790-798
- Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.Schizophr Res. 2016; 171: 62-67
- Concurrent and sustained cumulative effects of adolescent marijuana use on subclinical psychotic symptoms.Am J Psychiatry. 2016; 173: 781-789
- Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people.BMJ. 2005; 330: 11
- Prenatal nicotine exposure and risk of schizophrenia among offspring in a national birth cohort.Am J Psychiatry. 2016; 173: 799-806
- Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.Biochem Pharmacol. 2007; 74: 1182-1191
Available at: http://www.samhsa.gov/specific-populations/age-gender-based. Accessed September 1, 2016.
- The meaning of childhood attention-deficit hyperactivity symptoms in patients with a first-episode of schizophrenia-spectrum psychosis.Schizophr Res. 2011; 126: 28-35
- Comorbidity of schizophrenia and adult attention-deficit hyperactivity disorder.World J Biol Psychiatry. 2011; 12: 52-56
- Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap.Can J Psychiatry. 2015; 60: s48-s52
- Hallucinations and other psychotic symptoms associated with use of attention-deficit/hyperactivity disorder drugs in children.Pediatrics. 2009; 123: 611-616
- An experimental investigation of the phenomenology of delusional beliefs in people with Asperger syndrome.Autism. 2005; 9: 515-531
- A broad assessment of theory of mind in adolescence: the complexity of mindreading.Conscious Cogn. 2014; 24: 84-97
- Persecutory beliefs, attributes and theory of mind: comparison of patients with paranoid delusions, Asperger's syndrome and healthy controls.Schizophr Res. 2004; 69: 29-33
- The association between childhood autistic traits and adolescent psychotic experiences is explained by general neuropsychiatric problems.Am J Med Genet B. 2015; 171B: 153-159
- An advanced test of theory of mind: understanding of story characters' thoughts and feelings by able autistic, mentally handicapped and normal children and adults.J Autism Dev Disord. 1994; 24: 129-154
- Research on first-episode psychosis: report on a national institute of health workshop.Schizophr Bull. 1992; 18: 179-184
- The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia.Dialogues Clin Neurosci. 2006; 8: 109-113
Available at: http://www.mhs.com/product.aspx?gr=cli&prod=mccb&id=overview. Accessed September 1, 2016.
- Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment.Schizophr Res. 2014; 157: 33-39
- The MATRICS Consensus Cognitive Battery: what we know 6 years later.Am J Psychiatry. 2014; 171 ([commentary]): 1151-1154
- First-episode services for psychotic disorders in the U.S. public sector: a pragmatic randomized controlled trial.Psychiatr Serv. 2015; 66: 705-712
- The NAVIGATE program for first-episode psychosis: rationale, overview and description of psychosocial components.Psychiatr Serv. 2015; 66: 680-690
- Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program.Am J Psychiatry. 2016; 173: 362-372
- Proceedings and data from the Schizophrenia Summit: a critical appraisal to improve the management of schizophrenia.J Clin Psychiatry. 2009; 70: 4-46
- Progress and future directions in research on psychosis prodrome: a review for clinicians.Harv Rev Psychiatry. 2016; 24: 87-103
- Hippocampal and amygdala volumes according to psychosis stage and diagnosis a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.Arch Gen Psychiatry. 2006; 63: 139-149
- Severity of cortical thinning correlates with schizophrenia spectrum symptoms.J Am Acad Child Adolesc Psychiatry. 2016; 55: 130-136
- Cognitive course in first-episode psychosis and clinical correlates: a 4 year longitudinal study using the MATRICS Consensus Cognitive Battery.Schizophr Res. 2015; 169: 101-108
- Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): developmental data from two samples of volunteers.Schizophr Res. 2016; 172: 106-113
- Performance-based measures of functional skills: usefulness in clinical treatment studies.Schizophr Bull. 2007; 33: 1138-1148
- From linkage studies to epigenetics: what we know and what we need to know in the neurobiology of schizophrenia.Front Neurosci. 2016; 10: 202
- Genetics of childhood-onset schizophrenia.Child Adolesc Psychiatr Clin N Am. 2013; 22: 675-687
- Gray matter alteration in schizophrenia high-risk youth and early-onset schizophrenia a review of structural MRI findings.Child Adolesc Psychiatr Clin N Am. 2013; 22: 689-714
- Mapping adolescent brain change reveals dynamic wave of accelerated gray mater loss in very early-onset schizophrenia.Proc Natl Acad Sci U S A. 2001; 98: 11650-11655
- Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.Am J Psychiatry. 2013; 170: 609-615
- Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies.Schizophr Res. 2010; 120: 54-62
- Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study.Arch Gen Psychiatry. 1998; 55: 433-440
- Brain imaging during the transition from psychosis prodrome to schizophrenia.J Nerv Ment Dis. 2015; 203: 336-341
- New targets for prevention of schizophrenia: is it time for interventions in the premorbid phase?.Schizophr Bull. 2015; 41: 795-800
- Symptom assessment in schizophrenic prodromal states.Psychiatr Q. 1999; 70: 273-287
- Prevention of the first episode of psychosis.Psychiatr Clin North Am. 2011; 34: 95-107
- The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe.World Psychiatry. 2005; 4: 161-168
- Long-term follow up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 Study.JAMA Psychiatry. 2013; 70: 793-802
- North American prodrome longitudinal study: a collaborative multisite approach to prodromal schizophrenia research.Schizophr Bull. 2007; 33: 665-672
- North American Prodrome Longitudinal Study (NAPLS 2): the prodromal symptoms.J Nerv Ment Dis. 2005; 203: 328-335
- A case of attenuated psychosis syndrome: a broad differential diagnosis requires broad-spectrum treatment.Am J Psychiatry. 2016; 173: 321-329
Available at: http://www.rcpsych.ac.uk/pdf/Brief%20CAARMS%20with%20SOFAS%202016.pdf. Accessed May 30, 2016.
- Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.Schizophr Bull. 2007; 33: 792-796
- Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states.Aust N Z J Psychiatry. 2005; 39: 964-971
- Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.Schizophr Bull. 2003; 29: 703-715
- Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive value.Am J Psychiatry. 2002; 159: 863-865
- Personalized prediction of psychosis: external validation of the NAPLS-2 psychosis risk calculator with the EDIPPP Project.Am J Psychiatry. 2016; 173: 989-996
Available at: http://cape42.homestead.com/files/CAPE-42.htm. Accessed September 1, 2016.
Available at: http://www.schizophrenia.com/sztest/primetest.pdf. Accessed September 1, 2016.
- Psychosis risk screening with the prodromal questionnaire - brief version (PQ-B).Schizophr Res. 2011; 129: 42-46
- Longitudinal validation of psychosis risk screening tools.Schizophr Res. 2015; 165: 116-122
- The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population.Schizophr Bull. 2012; 38: 1288-1296
- The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis.Schizophr Res. 2012; 141: 210-214
- Screening tools for clinical high risk for psychosis.Early Interv Psychiatry. 2015; 9: 345-356
- The distribution of positive psychosis-like symptoms in the population: a latent class analysis of the National Comorbidity Survey.Schizophr Res. 2007; 89: 101-109
- Hallucinations in nonpsychotic children: more common than we think?.J Am Acad Child Adolesc Psychiatry. 1999; 38: 623-625
- Hallucinations in nonpsychotic children.J Am Acad Child Adolesc Psychiatry. 2000; 19 ([Letter to the Editor]): 12-13
- From phenomenology to neurophysiological understanding of hallucinations in children and adolescents.Schizophr Bull. 2014; 40: S221-S232
- Auditory verbal hallucinations in persons with and without a need for care.Schizophr Bull. 2014; 40: S255-S264
- A comprehensive review of auditory verbal hallucinations: lifetime prevalence, correlates and mechanisms in healthy and clinical individuals.Front Hum Neurosci. 2013; 7: 1-25
- The bidirectional association between psychotic experiences and DSM-IV mental disorders.Am J Psychiatry. 2016; 173: 997-1006
- The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey.Schizophr Res. 2008; 107: 179-185
- Straus (1969) revisited: a psychosis continuum in the general population?.Schizophr Res. 2000; 459: 11-20
- The incidence and outcome of subclinical psychotic experiences in the general population.Br J Clin Psychol. 2005; 44: 181-191
- Psychotic experiences in the general population: a twenty-year prospective community study.Schizophr Res. 2007; 92: 1-14
- Course of auditory vocal hallucinations in childhood: 11-year follow up study.Acta Psychiatr Scand. 2016; 134: 6-15
- Self-report of attenuated psychotic experiences in a college population.Schizophr Res. 2007; 93: 144-151
- Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia.Aust N Z J Psychiatry. 2009; 43: 118-128
- Healthy individuals with auditory verbal hallucinations: who are they? Psychiatric assessments of a selected sample of 103 subjects.Schizophr Bull. 2010; 36: 633-641
- The phenomenological critique and self-disturbance: implications for ultra-high risk (“prodrome”) research.Schizophr Bull. 2007; 34: 381-392
- Diagnosis and evaluation of hallucinations and other psychotic symptoms in children and adolescents.Child Adolesc Psychiatric Clin N Am. 2013; 22: 655-673
- Risk factors for psychosis in an ultra high risk group: psychopathology and clinical features.Schizophr Res. 2004; 67: 131-142
- Early interventions to prevent psychosis: systematic review and meta-analysis.BMJ. 2013; 346: 1-13
- Predicting psychosis: meta-analysis of transition outcomes.Arch Genpsychiatry. 2012; 69: 220-229
- The psychosis high-risk state: a comprehensive state-of-the-art review.JAMA Psychiatry. 2013; 70: 107-120
- Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials for 12 month and longer-term follow ups.Schizophr Res. 2013; 149: 56-62
- At clinical high risk for psychosis: outcome for nonconverters.Am J Psychiatry. 2011; 168: 800-805
- First-rank symptoms and premorbid adjustment in young individuals at increased risk of developing psychosis.Psychopathology. 2015; 48: 120-126
- The PRIME North American randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.Schizophr Res. 2003; 61: 7-18
- Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.Arch Gen Psychiatry. 2010; 67: 146-154
- Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study.Nat Commun. 2015; 6: 7934
- Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial.J Am Acad Child Adolesc Psychiatry. 2014; 53: 848-858
- Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial.Schizophr Bull. 2015; 41: 30-43
- Intervention for adolescents with early onset psychosis and their families: a randomized controlled trial.J Am Acad Child Adolesc Psychiatry. 2015; 53: 688-696
- Psychoeducation group intervention for adolescents with psychosis and their families: a two year follow-up.J Am Acad Child Adolesc Psychiatry. 2015; 54: 984-990
- Family intervention in first-episode psychosis: a qualitative systematic review.Sage Open. 2015; https://doi.org/10.117/2158244015613108
- Family interventions for schizophrenia and the psychoses: a review.Fam Process. 2016; 55: 460-482
- Four-year cost-effectiveness of cognitive behavior therapy for preventing first episode psychosis: the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.Schizophr Bull. 2016; https://doi.org/10.1093/schbul/sbw084
- Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial.Schizophr Bull. 2012; 38: 1180-1188
- Cognitive remediation for the treatment of cognitive dysfunction in the early course of psychosis.Harv Rev Psychiatry. 2016; 24: 164-172
- Enhancing cognitive training through aerobic exercise after a first schizophrenia episode: theoretical conception and pilot study.Schizophr Bull. 2016; 42: s42-s52
National Institute for Health and Care Excellence. Psychosis and schizophrenia in children and young people: recognition and management 2013. Clinical guideline; Available at: nice.org.uk/guidance/cg155nice.org.uk/guidance/cg155.
- What are the components of CBT for psychosis? A Delphi study.Front Psychol. 2010; 36: 136-142
- Hagen R. Turkington D. Berge R. CBT for psychosis: a symptom-based approach. The International Society for the Psychological Treatments of the Schizophrenias and Other Psychoses. Routledge, 2011
- Norcross J. Psychotherapy relationships that work. 2nd edition. Oxford University Press, 2011
- What's really wrong with cognitive behavior therapy for psychosis?.Front Psychol. 2015; https://doi.org/10.3389/psyg.2015.00232
- The evolution of cognitive behavior therapy for schizophrenia: current practice and recent developments.Schizophr Bull. 2009; 35: 865-873
- Psycholgocial interventions for psychosis: a meta-analysis of comparative outcome studies.Am J Psychiatry. 2014; 171: 525-528
- Management of psychosis and schizophrenia in adults: summary of updated NICE guidance.BMJ. 2014; 348https://doi.org/10.1136/bmj.g1173
- Practice parameter for the assessment and treatment of children and adolescents with schizophrenia.J Am Acad Child Adolesc Psychiatry. 2013; 52: 976-990
- The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.Schizophr Bull. 2010; 36: 71-93
- The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.Schizophr Bull. 2010; 36: 47-80
- Future research needs for first- and second- generation antipsychotics for children and young adults.Agency for Healthcare Research and Quality, Rockville (MD)2012 (Prepared by the RTI-UNC Evidence-based Practice Center under Contract No. 290 2007 10056 I); Future Research Needs Paper No. 13
- Off-label use of atypical antipsychotics: an update. (prepared by the Southern California Evidence-based Practice Center under contract no. HHSA290-2007-10062-1).Agency for Healthcare Research and Quality, Rockville (MD)2011 (Comparative Effectiveness Review No. 43)
- Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis.Am J Psychiatry. 2016 Sep 1; 173: 876-886
- Suicide and schizophrenia: a systematic review of rates and risk factors.J Psychopharm. 2010; : 81-90
- The RAISE connection program: psychopharmacological treatment of people with a first episode of schizophrenia.Psychiatr Serv Adv. 2015; 67: 1300-1306
- Coffee, cigarettes, and meds: what are the metabolic effects?.Psychiatr Times. 2005; (Available at:) (Accessed August 28, 2016)
- Cost effectiveness of comprehensive, integrated care for first episode psychosis in the NIMH RAISE early treatment program.Schizophr Bull. 2016; 42: 896-906
- The RAISE connection program for early psychosis: secondary outcomes and mediators and moderators of improvement.J Nerv Ment Dis. 2015; 203: 365-371
- State partnerships for first-episode psychosis Services.Psychiatr Serv. 2015; 66: 671-673
Article Info
Footnotes
Disclosure: Dr V. Chan has common stock holdings in AbbVie , Inc, Abbott Laboratories , Bristol-Myers Squibb Co , Eli Lilly & Co. , and Johnson & Johnson .
Identification
Copyright
© 2017 The Author. Published by Elsevier Inc.
User License
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
